| Medical Condition | Elevated Lipoprotein(a) |
| Facility/Clinic | Accellacare – 1202 Medical Center Dr |
| Age | 18+ |
| Gender | Male & Female |
| Description | A study to investigate the effect of Lepodisiran, a subcutaneous injection, with hopes to reduce the risk of major cardiovascular events (heart attacks, strokes, needing stents, bypass surgery) by decreasing lipoprotein a values. |
| Enrollment | Open |
| Patient Commitment Duration | 4-5 years |
| Number of visits in study | 24 (this includes an extended maintenance period) |
| Patient Compensation | Varies with each completed visit ranged from $28-$112 |
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.